Covid-19 drug prone to arrive December as procurement agreement in ultimate phases

The world’s first oral remedy for Covid-19 could presumably be available in Thailand from December, as a draft agreement nears completion. According to a Bangkok Post report, the Department of Medical Services chief says the draft procurement deal is awaiting authorized approval from the federal government.
Somsak Akksilp says his department is in talks with the Thai subsidiary of pharmaceutical large Merck, producers of the Molnupiravir pill, which has been shown to reduce back death and hospitalisation with Covid-19 by 50%. The drug works by creating an error within the genetic code of the virus and is the world’s first antiviral oral treatment for the treatment of Covid-19. Interim trials confirmed it was effective towards all variants.
Molnupiravir is awaiting emergency use approval from the US Food and Drug Administration and also will need the go-ahead from the Thai FDA before it may be administered in the kingdom. Somsak is hopeful that Thai FDA approval could presumably be forthcoming by November or December at the latest.
The DMS boss has previously refused to discuss the procurement value, telling the media that it was confidential information. However, he has confirmed the government has reserved 200,000 remedy courses. Merck plans to provide 10 million courses by the end of this 12 months.
“We can’t give more particulars on the amount to be bought as it would affect the company’s quota for ASEAN members. But ติดตั้งโซล่าเซลล์บ้าน ’m confident we are going to get it at an affordable worth.”

The Bangkok Post stories that Thailand is now working with Merck to ascertain if the drug can forestall Covid-19 an infection. The study might be carried out in 5 of the country’s major hospitals, together with Bangkok’s Rajavidhi Hospital.
SOURCE: Bangkok Post

Leave a Comment